RELATIVE SPARING OF ANTERIOR-PITUITARY FUNCTION IN PATIENTS WITH GROWTH HORMONE-SECRETING MACROADENOMAS - COMPARISON WITH NONFUNCTIONING MACROADENOMAS

被引:67
作者
GREENMAN, Y
TORDJMAN, K
KISCH, E
RAZON, N
OUAKNINE, G
STERN, N
机构
[1] ICHILOV HOSP, TEL AVIV ELIAS SOURASKY MED CTR, INST ENDOCRINOL, IL-64239 TEL AVIV, ISRAEL
[2] ICHILOV HOSP, TEL AVIV ELIAS SOURASKY MED CTR, DEPT NEUROSURG, IL-64239 TEL AVIV, ISRAEL
[3] TEL AVIV UNIV, SACKLER FAC MED, TEL AVIV, ISRAEL
关键词
D O I
10.1210/jc.80.5.1577
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pre- and postoperative anterior pituitary function was assessed in 26 subjects with nonfunctioning macroadenoma (NFMA) and in 15 acromegalic subjects with macroadenomas. Preoperatively, NFMA patients had a higher prevalence of secondary hypogonadism (78% vs. 40%; P < 0.05), hypothyroidism (23% vs. 0%; P = 0.06), and hypoadrenalism (43% vs. 7%; P = 0.02) compared to individuals with GH-secreting macroadenoma (GHMA). Patients with NFMA also had a higher prevalence of more severe pituitary failure compared with acromegalic patients; 56% of the patients in this group had more than one pituitary hormone axis impaired compared to only 8% in the acromegalic group. These differences could not be accounted for by tumor grade and/or stage. Transsphenoidal pituitary surgery led to a significant improvement in anterior pituitary function in the NFMA group. Nevertheless, the prevalence of pituitary deficiency postoperatively was still significantly greater in NFMA patients than in the acromegalic group (68% us. 17%, respectively; P < 0.04). The results suggest that anterior pituitary function is better preserved in GHMA than in NFMA and that this difference is independent of tumor size. The mechanism underlying the lower rate of hypopituitarism in acromegalics with macroadenomas remains to be elucidated.
引用
收藏
页码:1577 / 1583
页数:7
相关论文
共 24 条
[1]  
ARAFAH BM, 1987, J LAB CLIN MED, V109, P346
[2]   REVERSIBLE HYPOPITUITARISM IN PATIENTS WITH LARGE NONFUNCTIONING PITUITARY-ADENOMAS [J].
ARAFAH, PM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (06) :1173-1179
[3]  
BISHOP Y, 1976, DISCRETE MULTIVARIAT, P258
[4]   INSULIN-LIKE GROWTH FACTOR-I POTENTIATES THYROTROPIN STIMULATION OF ADENYLYL CYCLASE IN FRTL-5 CELLS [J].
BRENNERGATI, L ;
BERG, KA ;
GERSHENGORN, MC .
ENDOCRINOLOGY, 1989, 125 (03) :1315-1320
[5]   SIZE-REDUCTION OF MACROPROLACTINOMAS BY BROMOCRIPTINE OR LISURIDE TREATMENT [J].
CHIODINI, P ;
LIUZZI, A ;
COZZI, R ;
VERDE, G ;
OPPIZZI, G ;
DALLABONZANA, D ;
SPELTA, B ;
SILVESTRINI, F ;
BORGHI, G ;
LUCCARELLI, G ;
RAINER, E ;
HOROWSKI, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (04) :737-743
[6]  
COMTOIS R, 1991, CANCER, V68, P860, DOI 10.1002/1097-0142(19910815)68:4<860::AID-CNCR2820680431>3.0.CO
[7]  
2-4
[8]  
DANIEL PM, 1966, PITUITARY GLAND, V2, P535
[9]   LONG-TERM RESULTS IN TRANS-SPHENOIDAL REMOVAL OF NONFUNCTIONING PITUITARY-ADENOMAS [J].
EBERSOLD, MJ ;
QUAST, LM ;
LAWS, ER ;
SCHEITHAUER, B ;
RANDALL, RV .
JOURNAL OF NEUROSURGERY, 1986, 64 (05) :713-719
[10]  
GLEEHOLDDUIJVES.PH, 1989, ACTA ENDOCRINOL-COP, V121, P207